- Filed
- Aug 4, 2026
- Filings
- 2
- Signals
- 6
8-K · latest 5
What Johnson & Johnson's 8-K filings say
- SEC EDGAR
8-K
Filed · 3 signals
- SEC EDGAR
8-K
Filed · 3 signals
Johnson & Johnson completes acquisition of Firefly Bio, lowering 2026 margin guidance by ~150 bps.
The completed acquisition of Firefly Bio, combined with a new collaboration, will trigger post-merger integration and is projected to reduce 2026 adjusted pre-tax operating margin by approximately 150 basis points.
Firefly Bio, Inc.
The acquisition of Firefly Bio and a new collaboration with Sail Biomedicines will significantly impact short-term profitability, reducing 2026 adjusted EPS by $0.64.
Firefly Bio, Inc.Sail Biomedicines
The acquisition and strategic collaboration will reduce 2026 adjusted pre-tax operating margin by approximately 150 basis points and EPS by $0.64, indicating significant investment and integration costs.
Firefly Bio, Inc.Sail Biomedicines
Showing 5 of 6 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Johnson & Johnson with the Signal API
One POST /v1/companies/enrich call with jnj.com returns Johnson & Johnson 8-K signals (sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","signal_types":["sec-8k"],"limit":20}'Same industry
8-K at related companies
Questions about Johnson & Johnson 8-K
When did Johnson & Johnson file its latest 8-K?
What did Johnson & Johnson disclose in its latest 8-K?
Where can I read Johnson & Johnson's 8-K filing?
Source. Current reports (Form 8-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .